Yahoo Finance

Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline

BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) ...
Yahoo Finance

Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for Ulixacaltamide

BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
Investing

Praxis Precision shares target raised, holds buy rating on positive study data

On Wednesday, Needham maintained a Buy rating on shares of Praxis Precision Medicines Inc. (NASDAQ: PRAX) and increased the price target to $151 from $145. The adjustment follows Praxis's recent ...
Pacific Daily News

San Nicolas seeks to remove Praxis math test to address certified teacher shortage

Sen. Dwayne T.D. San Nicolas on Wednesday introduced Bill 282-37, which seeks to remove the Praxis mathematics requirement from the Guam initial educator certificate, saying this would address the ...